Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Vulvar Neoplasms × lenvatinib × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 33 Cholangiocarcinoma 11 Carcinoma, Renal Cell 7 Stomach Neoplasms 5 Neoplasms 4 Liver Neoplasms 4 Uterine Cervical Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Biliary Tract Neoplasms 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Kidney Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Breast Neoplasms 2 Advanced Solid Tumor 2 Vulvar Neoplasms 1 Urogenital Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumor, Adult 1 Solid Tumor 1 Sarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1

Interventions

Cisplatin 2 Carboplatin 2 trastuzumab deruxtecan 1 pembrolizumab 1 liposomal doxorubicin 1 lenvatinib 1 fludarabine 1 dostarlimab 1 belzutifan 1 aldesleukin 1 Vaccines, Synthetic 1 Therapeutic Touch 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiation 1 Platinum 1 Papillomavirus Vaccines 1 Paclitaxel 1 Nelfinavir 1 Imiquimod 1 Hysterectomy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Heavy Ion Radiotherapy 1 Gemcitabine 1 Electrochemotherapy 1 Drug Therapy 1 Doxorubicin 1 Dehydroepiandrosterone 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05903833 2025-09-09

PIERCE

AGO Research GmbH

Phase 2 Recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡